F2 Bioscience I 2017 Ltd has an estimated net worth of $11 Million. This is based on reported shares in Cullinan Oncology, Inc..
2022 was F2 Bioscience I 2017 Ltd's most active year for disposing of shares, totalling 3 transactions. F2 Bioscience I 2017 Ltd's most active month to dispose stocks was the month of May. In 2022 F2 Bioscience I 2017 Ltd cashed out on 101,903 shares for a total of $1,304,816.43, their largest year based on trade value.